Which test provides a definitive diagnosis of aplastic anemia?
Rationale:
Bone marrow aspiration provides a definitive diagnosis of aplastic anemia.
A definitive diagnosis of aplastic anemia requires direct examination of the bone marrow. Bone marrow aspiration and biopsy reveal hypocellularity with a significant reduction or absence of hematopoietic stem cells and their precursors, replaced by fat. This direct assessment of marrow architecture and cellularity is crucial for confirming the profound marrow failure characteristic of aplastic anemia, distinguishing it from other causes of pancytopenia.
A: Complete blood count with differential A CBC identifies pancytopenia (low red, white, and platelets), which is suggestive of aplastic anemia but does not reveal the underlying bone marrow failure directly.
C: Serum IgG levels Serum IgG levels assess immune function and are not directly indicative of bone marrow cellularity or the presence of aplastic anemia. This test offers no diagnostic value for this specific condition.
D: Basic metabolic panel A basic metabolic panel evaluates kidney function, electrolyte balance, and blood glucose, none of which directly diagnose or rule out bone marrow failure like aplastic anemia.
The best assessment of iron overload for patients with thalassemia major is achieved by
Rationale:
The best assessment of iron overload for patients with thalassemia major is achieved by liver MRI.
Liver MRI, specifically using T2 sequences, accurately quantifies hepatic iron concentration, which is a critical indicator of total body iron load in thalassemia major patients. This non-invasive method precisely measures tissue iron deposition, guiding chelation therapy and preventing organ damage. It offers superior sensitivity and specificity for assessing iron overload compared to other methods, making it the gold standard for management.
B: bone marrow biopsy Bone marrow biopsy assesses iron stores within marrow cells, but it offers limited insight into total body iron burden or specific organ iron concentration, making it unsuitable for comprehensive iron overload monitoring.
C: serum iron Serum iron measures circulating iron, which fluctuates significantly and does not reflect total body iron stores or tissue iron deposition accurately, thus providing an unreliable indicator for iron overload assessment.
D: serum ferritin Serum ferritin, while a common screening tool, can be elevated by inflammation or liver disease, leading to an overestimation of iron load and lacking the precision of direct organ iron measurement for therapy guidance.
The best treatment option for hereditary spherocytosis is
Rationale:
Splenectomy is the best treatment option for hereditary spherocytosis.
Hereditary spherocytosis involves fragile red blood cells that are prematurely destroyed in the spleen. Splenectomy removes the primary site of red blood cell destruction, significantly reducing hemolysis and improving anemia. While not a cure for the genetic defect, it effectively manages the most debilitating symptoms, making it the definitive long-term treatment for severe cases, particularly after infancy.
B: corticosteroids Corticosteroids are immunosuppressants, primarily used for autoimmune conditions like autoimmune hemolytic anemia. They do not address the underlying structural defect of red blood cells or the splenic sequestration characteristic of hereditary spherocytosis.
C: immunoglobulin Immunoglobulin therapy treats certain immune deficiencies or autoimmune disorders by modulating the immune system. It offers no therapeutic benefit for hereditary spherocytosis, which stems from a red blood cell membrane protein defect, not an immune issue.
D: cyclosporine Cyclosporine is an immunosuppressant used to prevent organ rejection or treat autoimmune diseases. It fails to correct the intrinsic red blood cell membrane defect or prevent their premature destruction in the spleen in hereditary spherocytosis.
A child with sickle cell disease is scheduled to have a splenectomy. What is the primary reason for this surgery?
Rationale:
To prevent splenic sequestration is the primary reason for a splenectomy in a child with sickle cell disease.
Splenic sequestration is a life-threatening complication in sickle cell disease where the spleen rapidly pools a large volume of red blood cells, leading to severe anemia, hypovolemic shock, and potentially death. Removing the spleen eliminates the organ responsible for this acute, dangerous blood pooling, thereby preventing future episodes and improving the child's long-term prognosis by removing a significant mortality risk.
A: To decrease the potential for infection A splenectomy actually increases the risk of severe bacterial infections, particularly from encapsulated organisms, rather than decreasing it, necessitating lifelong prophylactic antibiotics.
C: To prevent sickling of red blood cells Splenectomy does not alter the fundamental genetic defect causing red blood cell sickling; it only removes an organ that can become damaged or dangerously affected by sickled cells.
D: To prevent a sickle cell crisis While it prevents the specific crisis of splenic sequestration, splenectomy does not prevent other forms of sickle cell crises, such as vaso-occlusive crises or acute chest syndrome, which stem from widespread sickling.
Deficiency of which of the following factors is asymptomatic?
Rationale:
Deficiency of factor XII is asymptomatic.
Factor XII deficiency typically presents without any bleeding symptoms, even in severe cases, making it an asymptomatic condition. Despite its role in the intrinsic pathway of coagulation, its absence does not impair hemostasis significantly in vivo. Patients often discover this deficiency incidentally through prolonged activated partial thromboplastin time (aPTT) tests during routine screening or before surgery, rather than due to clinical bleeding episodes.
A: factor VII Factor VII deficiency causes significant bleeding, ranging from mild to severe, including epistaxis, menorrhagia, and intracranial hemorrhage, due to its crucial role in initiating the extrinsic pathway.
B: factor VIII Factor VIII deficiency leads to hemophilia A, a severe bleeding disorder characterized by spontaneous joint and muscle bleeds, prolonged bleeding after injury, and serious internal hemorrhages.
C: factor IX Factor IX deficiency results in hemophilia B, another severe X-linked bleeding disorder manifesting with spontaneous deep tissue bleeds, hemarthrosis, and excessive bleeding post-trauma or surgery.
One of the following factors is not available in cryoprecipitate
Rationale:
Factor V is not available in cryoprecipitate.
Cryoprecipitate is a cold-insoluble plasma protein fraction obtained from fresh frozen plasma. It is rich in high molecular weight proteins that precipitate upon thawing at 1-6°C. While it contains fibrinogen, Factor VIII (which includes von Willebrand factor), and Factor XIII, it notably lacks Factor V. Factor V remains in the cryo-poor plasma fraction, making cryoprecipitate an unsuitable source for its replacement.
A: von-Willebrand factor This crucial hemostatic glycoprotein is a known component of cryoprecipitate, co-precipitating with Factor VIII, making it a valuable therapeutic source for vWD.
B: Factor XIII Fibrin stabilizing factor (Factor XIII) is indeed present in cryoprecipitate, contributing to its hemostatic properties by cross-linking fibrin, enhancing clot stability.
D: Fibrinogen As the primary component by mass, fibrinogen is abundantly concentrated in cryoprecipitate, making it a critical treatment for hypofibrinogenemia and dysfibrinogenemia.
Lupus anticoagulants usually affect the following laboratory test
Rationale:
Lupus anticoagulants usually affect the partial thromboplastin time (PTT).
Lupus anticoagulants are antibodies that interfere with phospholipid-dependent coagulation tests, primarily prolonging the partial thromboplastin time (PTT) by inhibiting components of the intrinsic pathway in vitro. Despite their name, these autoantibodies are associated with a prothrombotic state in vivo, not bleeding. Their presence necessitates further investigation for thrombotic risk assessment and proper clinical management.
A: bleeding time (BT) This test assesses platelet function and vascular integrity. Lupus anticoagulants directly impact coagulation factors, not primary hemostasis components, hence BT remains unaffected by their presence.
C: prothrombin time (PT) The PT evaluates the extrinsic and common coagulation pathways. While some lupus anticoagulants might mildly prolong PT, PTT prolongation is far more
The standard care for MOST children with severe hemophilia is
Rationale:
Prevention by F VIII replacement therapy to prevent spontaneous bleeding and early joint deformities is the standard care for most children with severe hemophilia.
This option accurately describes prophylaxis, the gold standard for severe hemophilia. Regular factor VIII infusions prevent spontaneous bleeds, particularly into joints, which significantly reduces chronic arthropathy and preserves joint function, thereby improving quality of life and long-term outcomes for affected children. This proactive approach minimizes disabling complications from an early age.
B: aggressive treatment by F VIII replacement therapy when significant bleeding occurs This describes on-demand therapy, which treats bleeds after they manifest, rather than preventing them. While necessary for acute episodes, it fails to prevent cumulative joint damage and long-term disability, making it a suboptimal primary strategy.
C: avoid trauma While avoiding trauma is prudent, it is an insufficient standalone strategy for severe hemophilia. Spontaneous bleeding, often without apparent injury, remains a significant risk, necessitating active medical intervention beyond mere avoidance.
D: avoid aspirin and other NSAID Avoiding these medications is crucial due to their antiplatelet effects, which exacerbate bleeding risk. However, this is a supportive measure for managing hemophilia, not the primary, comprehensive standard of care that addresses the core deficiency.
A previously normal 10-year-old male experiences pallor, fatigue, and a fall in hemoglobin level from 13 to 8 g/dL without evidence of bleeding. His spleen is slightly enlarged. The reticulocyte count is 10%, and his WBC and platelet counts are normal. Many spherocytes are observed on the blood film. The most likely diagnosis is
Rationale:
Hereditary spherocytosis is the most likely diagnosis.
The child's presentation with pallor, fatigue, significant anemia, splenomegaly, and a markedly elevated reticulocyte count (10%) strongly indicates hemolytic anemia. The critical finding of "many spherocytes" on the blood film, without evidence of bleeding, is pathognomonic for hereditary spherocytosis, a genetic condition causing red blood cell membrane defects and premature destruction.
B: G-6-PD deficiency This condition causes episodic hemolytic anemia, often triggered by oxidative stress, and is characterized by Heinz bodies, not primarily numerous spherocytes. The continuous high reticulocyte count also suggests a different mechanism.
C: pyruvate kinase (PK) deficiency PK deficiency is a hemolytic anemia, but typically red blood cell morphology shows echinocytes or burr cells, not the prominent spherocytes observed here. The specific cell shape is crucial for differentiation.
D: occult bleeding The question explicitly states "without evidence of bleeding." Furthermore, occult bleeding would lead to iron deficiency anemia, which would not present with spherocytes or such a high reticulocyte count, indicative of hemolysis.
Fragmentation hemolysis by mechanical injury may be seen in all the following EXCEPT
Rationale:
Extensive burns are not typically associated with fragmentation hemolysis due from mechanical injury.
Fragmentation hemolysis involves red blood cell destruction due to mechanical trauma within microvasculature or around foreign bodies. While burns can cause hemolysis, it's primarily thermal, osmotic, or oxidative, leading to direct red cell damage or spherocytosis, not typically mechanical fragmentation from microangiopathic processes or prosthetic devices. Therefore, extensive burns stand apart from other conditions listed.
B: Kasabach-Merritt syndrome involves giant hemangiomas that trap platelets and red blood cells, leading to severe microangiopathic hemolytic anemia with fragmentation due to turbulent flow and fibrin deposition within the abnormal vasculature.
C: after cardiac surgery for prosthetic heart valve replacement Prosthetic heart valves, especially mechanical ones, create turbulent blood flow and shear stress, physically damaging red blood cells as they pass, resulting in characteristic fragmentation hemolysis often manifesting as microangiopathic hemolytic anemia.
D: thrombotic thrombocytopenic purpura (TTP) TTP is a microangiopathic hemolytic anemia characterized by widespread platelet thrombi in small blood vessels, which physically shear red blood cells as they attempt to pass, causing fragmentation and schistocyte formation.
Appropriate long-term management of the disease described in Question 3 includes all of the following EXCEPT
Rationale:
Splenectomy is NOT an appropriate long-term management of the disease described in Question 3.
Splenectomy involves surgically removing the spleen, which is primarily relevant for conditions involving red blood cell destruction or platelet disorders, like immune thrombocytopenia. Hemophilia A is a genetic bleeding disorder caused by a deficiency in clotting factor VIII, not a splenic dysfunction. Therefore, removing the spleen offers no therapeutic benefit for managing hemophilia's core coagulopathy, making it an entirely inappropriate intervention.
A: avoiding aspirin Aspirin inhibits platelet aggregation and can exacerbate bleeding in hemophiliacs, making its avoidance crucial for preventing hemorrhagic complications and maintaining hemostasis in these patients.
B: hepatitis B vaccination Hemophilia patients historically received blood products, increasing their risk of blood-borne infections. Hepatitis B vaccination provides essential protection against this common transfusion-related viral threat.
C: home replacement factor VIII therapy Regular, prophylactic infusions of factor VIII concentrate at home are the cornerstone of modern hemophilia management, preventing spontaneous bleeding episodes and enabling a near-normal lifestyle.
Which of the following conditions causes profound thrombocytopenia?
Rationale:
Disseminated intravascular coagulation causes profound thrombocytopenia.
Disseminated intravascular coagulation (DIC) triggers widespread activation of the coagulation cascade, leading to the formation of numerous microthrombi throughout the microvasculature. This pathological process rapidly consumes platelets and clotting factors at an accelerated, uncontrolled rate. The continuous, systemic consumption of circulating platelets, coupled with potential impaired bone marrow response, results in a severe and often acute reduction in platelet count, defining profound thrombocytopenia.
B: liver failure Liver failure impairs thrombopoietin synthesis and can cause splenic sequestration, contributing to moderate thrombocytopenia. It generally doesn't induce the severe, rapid platelet consumption characteristic of DIC.
C: vitamin k deficiency Vitamin K deficiency primarily impacts the hepatic synthesis of specific coagulation factors (II, VII, IX, X) crucial for clotting. It does not directly cause a significant reduction in platelet count.
D: sepsis without shock Sepsis without shock can induce mild to moderate thrombocytopenia through platelet activation and consumption. However, it rarely precipitates the extreme platelet depletion seen in DIC unless the condition progresses to full-blown DIC.
Which factors should be included in a teaching plan for a child with sickle cell anemia? (Select one that does not apply..)
Rationale:
The parent should ensure the child sleeps in an air-conditioned room.
Ensuring a child with sickle cell anemia sleeps in an air-conditioned room is not a standard or beneficial teaching point. Extreme cold or rapid temperature changes can precipitate vaso-occlusive crises by causing vasoconstriction and increasing blood viscosity. Maintaining a stable, moderate environmental temperature is essential to prevent these triggers, making air conditioning potentially counterproductive if it leads to excessive cooling.
A: The child needs to be taken to a
All the following are correct regarding treatment of cold agglutinin disease EXCEPT
Rationale:
Glucocorticoids treatment is a modality of treatment is the exception among the listed options regarding cold agglutinin disease treatment.
Glucocorticoids are generally ineffective in treating cold agglutinin disease (CAD) because the autoantibodies involved are typically IgM, and their production is often not responsive to steroid therapy. Unlike warm autoimmune hemolytic anemia, where steroids are a cornerstone, CAD management focuses on avoiding triggers and addressing the underlying clonal B-cell proliferation, making glucocorticoids largely unsuitable as a primary treatment.
A: patient should avoid exposure to cold. Cold agglutinin disease is exacerbated by low temperatures, directly causing agglutination and hemolysis. Preventing cold exposure is a fundamental, essential first-line management strategy to reduce symptom severity and hemolytic episodes.
B: patient should be treated for underlying disease. Cold agglutinin disease is frequently secondary to lymphoproliferative disorders like lymphoma or Mycoplasma pneumonia. Addressing the underlying condition can effectively reduce cold agglutinin production, often leading to significant improvement in hematologic parameters.
C: plasmapheresis is a modality of treatment. Plasmapheresis effectively removes circulating cold agglutinins, providing temporary relief, especially in severe, acute hemolytic crises. This intervention rapidly reduces antibody levels, mitigating immediate agglutination and associated circulatory complications.
The nurse is taking care of a child with sickle cell disease. The nurse is aware that which of the following problems is (are) associated with sickle cell disease? (Select all that apply.)
Rationale:
Aplastic crisis is a problem associated with sickle cell disease.
Sickle cell disease involves chronic hemolysis, leading to profound anemia. Parvovirus B19 infection can transiently suppress erythropoiesis in the bone marrow, causing a severe drop in red blood cell production. This sudden cessation of red blood cell formation, combined with the already shortened lifespan of sickle cells, precipitates a life-threatening aplastic crisis characterized by severe anemia and reticulocytopenia, requiring urgent medical intervention.
A: Polycythemia Polycythemia signifies an abnormally high red blood cell count, which directly contradicts the characteristic anemia and red blood cell destruction inherent in sickle cell disease pathophysiology.
B: Hemarthrosis Hemarthrosis, or bleeding into joints, is typically a complication of coagulation disorders like hemophilia, not a direct pathological feature of red blood cell sickling.
D: Thrombocytopenia Thrombocytopenia, a low platelet count, is not a primary or common direct complication of sickle cell disease; rather, it’s often associated with other conditions or treatments.
An 18-month-old male is brought in by his mother. He is pale, and his hematocrit is 20%. Which questions should help the nurse make a diagnosis?.)
Rationale:
What does your child eat every day?
In an 18-month-old with pallor and low hematocrit, inquiring about daily dietary intake is paramount. This question directly assesses the child'
A 9-month-old child with a hemoglobin concentration of $10 \mathrm{gm} / \mathrm{dL}$ and marked microcytosis; serum iron and total iron binding capacity are within normal limits; serum ferritin and hemoglobin electrophoresis are also normal. Of the following, the MOST likely diagnosis is
Rationale:
α-thalassemia trait is the MOST likely diagnosis.
α-thalassemia trait presents with microcytic anemia and normal iron studies (serum iron, TI
A 10-month-old white male presents with a 1-day history of persistent bleeding after cutting his lip slightly. The family history is unremarkable, and the patient is receiving no medications. Laboratory data reveal a hemoglobin value of 11 g/dL, platelets of 350,000, a prothrombin time of 11.8 seconds, and a partial thromboplastin time (PTT) of 100 seconds, which is corrected by mixing of normal plasma. The most likely diagnosis is
Rationale:
The most likely diagnosis is hemophilia A.
Hemophilia A, a deficiency of factor VIII, is the most probable cause. The significantly prolonged partial thromboplastin time (PTT) corrected by
The urgency for packed cell transfusion in childhood anemia should be dictated by
Rationale:
The urgency for packed cell transfusion in childhood anemia should be dictated by the extent of functional impairment.
Correct Option Explanation: The extent of functional impairment, characterized by clinical signs like severe tachycardia, breathlessness, or profound lethargy, is crucial. These symptoms indicate significant organ compromise, irrespective of the absolute hemoglobin value. A child's physiological response to anemia, rather than just a number, dictates the immediate need for transfusion to alleviate acute distress and prevent critical organ damage, ensuring timely intervention.
A: absolute level of hemoglobin While hemoglobin levels indicate anemia severity, they don't solely dictate transfusion urgency. Chronically anemic children often tolerate lower levels well; acute functional compromise is a more immediate indicator for intervention.
C: age of the patient Patient age influences normal hemoglobin ranges and compensatory mechanisms, but it is not the primary determinant for acute transfusion urgency. Clinical stability and functional status remain the paramount considerations for immediate intervention.
D: gender of the patient Gender typically has minimal impact on the urgency of packed cell transfusion in childhood anemia. Hemoglobin reference ranges might vary slightly by gender in adulthood, but it is not a direct factor for acute clinical decision-making regarding transfusion.
In the patient described in Questions 10 and 11, when the hemoglobin and hematocrit return to normal, which should be done?
Rationale:
Continue iron for 4-8 weeks when hemoglobin and hematocrit return to normal.
Iron supplementation must persist for 4-8 weeks after hemoglobin and hematocrit normalize to replenish iron stores adequately. While blood counts reflect circulating iron, ferritin levels, indicating storage, lag behind. This prolonged therapy ensures marrow iron stores are refilled, preventing rapid relapse of iron deficiency and maintaining long-term hematological stability.
A: Stop iron supplementation. Stopping iron immediately prevents complete replenishment of body iron stores, leaving the patient vulnerable to rapid recurrence of anemia due to depleted ferritin levels.
B: Continue iron for 1-2 weeks. This duration is demonstrably insufficient to fully replete iron stores even after hemoglobin normalizes, risking a swift return to iron deficiency.
D: Continue iron for 4-7 days. Such a brief continuation provides no meaningful benefit for restoring crucial iron reserves, making subsequent iron deficiency highly probable post-treatment.
Matching: For each of the following disorders, select the appropriate platelet presentation - Kawasaki disease
Rationale:
Platelets increased is the appropriate platelet presentation for Kawasaki disease.
Kawasaki disease typically presents with thrombocytosis, meaning an elevated platelet count, especially during the subacute phase of the illness, which is crucial for diagnosis and monitoring. This increase reflects the systemic inflammatory response characteristic of the vasculitis. High platelet numbers contribute to the risk of coronary artery aneurysms and thrombosis, requiring careful management.
A: Platelets decreased in number Thrombocytopenia is not characteristic of Kawasaki disease; instead, it is often seen in conditions like immune thrombocytopenic purpura or severe sepsis, presenting a different hematological profile.
B: Platelet count normal A normal platelet count is atypical for the active phases of Kawasaki disease, which consistently involves a significant inflammatory response leading to marked thrombocytosis, distinguishing it from other febrile illnesses.
Which of the following is FALSE about factor V Leiden mutation?
Rationale:
Heterozygotes have an increased risk of arterial thrombosis is FALSE about factor V Leiden mutation.
Factor V Leiden mutation primarily confers an increased risk of venous thromboembolism, such as deep vein thrombosis and pulmonary embolism, not arterial thrombosis. While any thrombotic predisposition can theoretically impact arterial events, the established and significant association for factor V Leiden is with venous clot formation. Therefore, stating an increased risk of arterial thrombosis for heterozygotes misrepresents its primary pathological mechanism.
A: it is the most common inherited risk factor for thrombosis Factor V Leiden is indeed the most prevalent inherited thrombophilia, significantly predisposing individuals to venous clotting events worldwide.
B: heterozygous individuals have less risk for thrombosis than homozygotes Homozygosity for factor V Leiden confers a substantially higher thrombotic risk compared to the milder, though still elevated, risk associated with heterozygosity.
D: there is an increased frequency of thrombosis while receiving oral contraceptive agents Oral contraceptive use significantly amplifies the thrombotic risk in individuals carrying the factor V Leiden mutation, leading to a synergistic effect.
A 28-year-old black man with sickle cell disease presents to the emergency department with abdominal pain, chest pain, and shortness of breath. His dyspnea evolved over 36 hours after a visit with his niece and nephew. His history is significant for approximately 2 emergency department visits or hospital admissions per year for painful crises. Three years ago, he spent 4 weeks in the hospital after an episode of acute chest syndrome. He has been taking hydroxyurea but only intermittently because of financial concerns. His pulse is 116 beats per minute and regular, his blood pressure is 138/76 mm Hg, his respiratory rate is 18 breaths per minute, and his temperature is 38.3°C. Pulse oximetry shows 91% oxygen saturation with room air and 93% with 4 L of oxygen by nasal cannula. His lungs have scattered inspiratory crackles in the right midlung field. His spleen is not palpable. The remainder of the physical examination findings are normal. Diagnostic testing results are shown in Table 9.Q4. A chest radiograph shows a right middle and upper lobe air space infiltrate. The patient is given supplemental oxygen, adequate pain control, and intravenous antibiotics. Which of the following should you now order?
Rationale:
Erythrocyte exchange transfusion should now be ordered.
Erythrocyte exchange transfusion is crucial for severe acute chest syndrome (ACS), characterized by hypoxemia (91% O2 sat),
Spontaneous intracranial hemorrhage is more likely to occur in
Rationale:
Spontaneous intracranial hemorrhage is more likely to occur in factor XIII deficiency.
Factor XIII deficiency profoundly impairs stable fibrin clot formation, leading to fragile hemostasis. This significantly elevates the risk of life-threatening, spontaneous bleeding, particularly in critical sites like the intracranial space. The compromised ability to cross-link fibrin monomers results in delayed and persistent hemorrhages, making intracranial bleeding a common and severe manifestation of this rare coagulation disorder.
A: factor VII deficiency Factor VII deficiency causes a bleeding diathesis, but intracranial hemorrhage is less consistently highlighted as a spontaneous, predominant feature compared to factor XIII deficiency's profound impact on clot stability.
B: factor VIII deficiency Factor VIII deficiency, or hemophilia A, primarily causes deep tissue bleeding and hemarthroses due to impaired intrinsic pathway function, with spontaneous intracranial hemorrhage being a less common initial presentation than with factor XIII issues.
C: factor IX deficiency Factor IX deficiency, or hemophilia B, also leads to a bleeding disorder characterized by hemarthroses and muscle hematomas from intrinsic pathway defects, not the severe, spontaneous intracranial bleeding typical of factor XIII's clot stabilization failure.
Transfusion of fresh frozen plasma (FFP) is efficacious for the treatment of deficiency of all the following coagulation factors EXCEPT
Rationale:
Transfusion of fresh frozen plasma (FFP) is efficacious for the treatment of deficiency of all the listed coagulation factors EXCEPT factor XIII.
FFP contains all plasma coagulation factors in normal concentrations, making it effective for deficiencies of factors V, X, and XI. However, factor XIII deficiency typically manifests with bleeding symptoms but FFP is not the primary or most efficacious treatment. Cryoprecipitate, which has a higher concentration of factor XIII, is generally preferred for treating factor XIII deficiency, making FFP less optimal in this specific case.
A: factor V FFP contains abundant factor V, making it an appropriate and effective treatment choice for patients with inherited or acquired factor V deficiency to restore hemostasis.
B: factor X FFP is rich in factor X, providing a readily available source to correct bleeding in individuals suffering from factor X deficiency, thereby supporting normal coagulation pathways.
C: factor XI FFP contains significant levels of factor XI, rendering it a viable therapeutic option for patients experiencing bleeding due to congenital or acquired factor XI deficiency.
Iron deficiency anemia is less prevalent in breast fed infants because
Rationale:
Iron deficiency anemia is less prevalent in breastfed infants because iron in human milk is more efficiently absorbed.
Human milk contains lactoferrin, a protein that binds iron and facilitates its absorption in the infant's gut. This high bioavailability, despite lower absolute iron content compared to some formulas, ensures that the infant utilizes the available iron more effectively. This enhanced absorption minimizes the risk of iron deficiency anemia in breastfed babies during their initial months, leveraging the biological advantages of human milk
Vitiligo, glossitis, ataxia, and peripheral neuropathy are features of
Rationale:
Vitamin B12 deficiency is characterized by vitiligo, glossitis, ataxia, and peripheral neuropathy.
Vitamin B12 (cobalamin) deficiency manifests with a broad spectrum of neurological and dermatological symptoms. Peripheral neuropathy and ataxia arise from demyelination and neuronal damage. Glossitis indicates tongue inflammation, a common sign. Vitiligo, an autoimmune depigmentation, is also frequently associated due to B12's role in melanin production and immune regulation, making this the most comprehensive match.
A: iron deficiency anemia Iron deficiency anemia primarily causes fatigue, pallor, pica, and koilonychia; it does not typically present with the neurological symptoms of ataxia or peripheral neuropathy, nor vitiligo.
C: folic acid deficiency Folic acid deficiency shares megaloblastic anemia and glossitis with B12, but it rarely causes the significant neurological deficits like ataxia or peripheral neuropathy observed here.
D: heavy metal intoxication Heavy metal intoxication can cause neuropathy and ataxia, but it seldom leads to vitiligo or glossitis, and its symptomatic profile is generally distinct from a vitamin deficiency.
An illogical cause of failure of increment of hemoglobin after starting treatment of iron deficiency anemia is
Rationale:
An illogical cause of failure of increment of hemoglobin after starting treatment of iron deficiency anemia is excessive formula milk intake.
Excessive formula milk intake is an illogical cause of treatment failure because while it causes
A 5-year-old child, with hemophilia A of severe type, presents to the emergency unit with a groin pain after a minor trauma to his back; his blood pressure is $60 / 30 \mathrm{~mm} \mathrm{Hg}$; his pulse rate is $180 / \mathrm{min}$; he holds his right hip in a flexion position with internal rotation. Of the following, the NEXT step in the management of this child is
Rationale:
Factor VIII replacement therapy is the NEXT step in the management of this child.
The child presents with severe hemophilia A, signs of hypovolemic shock (BP 60/30, HR 180), and symptoms suggesting a significant retroperitoneal or iliopsoas bleed following trauma. Immediate factor VIII replacement is crucial to stop the life-threatening hemorrhage and stabilize the patient. Delaying treatment risks further blood loss and catastrophic outcomes in a severe hemophiliac. This direct intervention addresses the underlying coagulopathy.
B: intravenous 1-deamino-8-d-arginine vasopressin (DDAVP) DDAVP primarily works in mild to moderate hemophilia A by releasing endogenous factor VIII. It is ineffective for severe hemophilia A, where
Arterial thrombosis is the least likely cause of
Rationale:
Pulmonary embolism is the least likely condition to be caused by arterial thrombosis.
Pulmonary embolism typically arises from venous thromboembolism (VTE), where a clot forms in a deep vein, often in the legs, then dislodges and travels to the pulmonary arteries. Arterial thrombosis, forming in arteries due to atherosclerosis or other arterial injury, primarily causes localized ischemia in the arterial distribution, making it an infrequent source for emboli reaching the lungs.
A: stroke Arterial thrombosis frequently leads to ischemic stroke when a clot occludes a cerebral artery, depriving brain tissue of oxygen and nutrients.
B: a cold and pulseless lower extremity Acute arterial thrombosis in a limb artery directly obstructs blood flow, causing severe ischemia characterized by coldness, pallor, and absent pulses distally.
C: renal infarction Thrombosis within a renal artery or its branches directly impedes blood supply to kidney tissue, resulting in localized cellular death and impaired organ function.